Thrombolysis and Acute Stroke Treatment (TAST) is a conference dedicated to future directions of clinical practice and research to enhance medical care in the acute treatment of ischemic stroke including topics such as:
- The safety and efficacy of thrombolytic agents currently used or being developed for acute stroke treatment
- The neurovascular unit and its injury
- Time window considerations and optimized delivery conditions
- New views of the penumbra
- Enhancing the safety of plasminogen activators
- Stabilization of brain tissue for patient recovery
- Alternative approaches in stroke treatment
- Factors that influence risk and benefit
Thrombolysis and Acute Stroke Treatment (TAST) brings together clinicians, physicians and scientists interested in cerebrovascular disease.
